Eplerenone in patients with systolic heart failure and mild symptoms

Zannad, Faiez, McMurray, John J.V., Krum, Henry, van Veldhuisen, Dirk J., Swedberg, Karl, Shi, Harry, Vincent, John, Pocock, Stuart J. +1 more·2011·New England Journal of Medicine

DOI 10.1056/nejmoa1009492

Cited by (1,005)

Items 301–400 of 1,005

The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysis
Kevin Quach, Lyubov Lvtvyn, Colin Baigent, Joe Bueti, Amit X. Garg, Carmel Mary Hawley, Richard Haynes, Braden Manns, Vlado Perkovic, Christian G. Rabbat et al. · 2016 · American Journal of Kidney Diseases
Mechanisms and Drug Development in Atrial Fibrillation
David Calvo, David Filgueiras Rama, José Jalife · 2018 · Pharmacological Reviews
Accelerated and personalized therapy for heart failure with reduced ejection fraction
Li Shen, Pardeep S. Jhund, Kieran F. Docherty, Muthiah Vaduganathan, Mark Colquhoun Petrie, Akshay Suvas Desai, Lars Køber, Morten Schou, Milton Packer, Scott David Solomon et al. · 2022 · European Heart Journal
Mechanisms of ligand specificity of the mineralocorticoid receptor
Peter J. Fuller, Yizou Yao, Jun Yang, Morag J. Young · 2011 · Journal of Endocrinology
Endothelial Mineralocorticoid Receptors Differentially Contribute to Coronary and Mesenteric Vascular Function Without Modulating Blood Pressure
Katelee Barrett Mueller, Shawn B. Bender, Kwangseok Hong, Yan Yang, Mark A. Aronovitz, Frédéric Jaisser, Michael A. Hill, Iris Zamir Jaffe · 2015 · Hypertension
Estrogen Receptor Inhibits Mineralocorticoid Receptor Transcriptional Regulatory Function
Katelee Barrett Mueller, Qing Richard Lu, Najwa N. Mohammad, Victor Luu, Amy McCurley, Gordon H. Williams, Gail Kurr Adler, Richard H. Karas, Iris Zamir Jaffe · 2014 · Endocrinology
Sacubitril/valsartan in heart failure with reduced ejection fraction patients: Real world experience on advanced chronic kidney disease, hypotension, and dose escalation
Hung‐Yu Chang, An-Ning Feng, Man-Cai Fong, Chao-Wen Hsueh, Wei‐Tsung Lai, Kuan‐Chih Huang, Eric Y. Chong, Chi-Nan Chen, Hung-Chuan Chang, Wei‐Hsian Yin · 2019 · Journal of Cardiology
Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes
Rajiv Agarwal, Luis Miguel Ruilope, Gema Ruiz‐Hurtado, Hermann G. Haller, Roland Erich Schmieder, Stefan D. Anker, Gerasimos S Filippatos, Bertram Pitt, Peter R Rossing, Marc Lambelet et al. · 2022 · Journal of Hypertension
How to Tackle Therapeutic Inertia in Heart Failure with Reduced Ejection Fraction. A Scientific Statement of the Heart Failure Association of the ESC
Gianluigi Savarese, Felix Lindberg, Antonio Nicola Cannata, Ovidiu Chioncel, Davide Stolfo, Francesca Musella, Daniela Tomasoni, Magdy Abdelhamid, Debasish Banerjee, Antoni Bayés‐Genís et al. · 2024 · European Journal of Heart Failure
2024 EACTS Guidelines on perioperative medication in adult cardiac surgery
Anders Jeppsson, (Co-Chairperson) (Sweden), Bianca Rocca, (Co-Chairperson) (Italy), Emma C. Hansson, (Sweden), Tómas Guðbjartsson, (Iceland), Stefan Karl James, (Sweden) et al. · 2024 · European Journal of Cardio-Thoracic Surgery
Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms
Linda Shavit, Meyer D. Lifschitz, Murray Epstein · 2012 · Kidney International
2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure: Executive Summary
Paul A. Heidenreich, Biykem Bozkurt, David A. Aguilar, Larry A. Allen, Joni J. Byun, Monica M Colvin, Anita M Deswal, Mark H. Drazner, Shannon M. Dunlay, Linda R. Evers et al. · 2022 · Journal of Cardiac Failure
Adipocytes, aldosterone and obesity-related hypertension
Aurélie Nguyen Dinh Cat, Malou Friederich‐Persson, Anna D. White, Rhian M. Touyz · 2016 · Journal of Molecular Endocrinology
Autophagy Stimulation and Intracellular Sodium Reduction as Mediators of the Cardioprotective Effect of Sodium–Glucose Cotransporter 2 Inhibitors
Milton Packer · 2020 · European Journal of Heart Failure
Extended heart failure clinic follow-up in low-risk patients: a randomized clinical trial (NorthStar)
Morten Schou, Finn Gustafsson, Lars Melgaard Videbæk, Christian Tuxen, Niels Keller, Jens Handberg, Anne Sejr Knudsen, Geert Tschentscher Espersen, John Markenvard, Kenneth Egstrup et al. · 2012 · European Heart Journal
Novel Protein Therapeutics for Systolic Heart Failure
Horng H. Chen, James F. Glockner, John A. Schirger, Alessandro Cataliotti, Margaret M. Redfield, John C. Jr Burnett · 2012 · Journal of the American College of Cardiology
Which Heart Failure Patients Profit from Natriuretic Peptide Guided Therapy? a Meta-Analysis from Individual Patient Data of Randomized Trials
Hans‐Peter Brunner‐La Rocca, Luc W.M. Eurlings, Mark Richards, James L. Januzzi, Matthias Emil Pfisterer, Ulf Dahlström, Yigal M. Pinto, Patric Karlström, Hans Erntell, Rudolf Berger et al. · 2015 · European Journal of Heart Failure
Statistical Controversies in Reporting of Clinical Trials
Stuart Pocock, John J.V. McMurray, Timothy John Collier · 2015 · Journal of the American College of Cardiology
Mechanical Unloading Promotes Myocardial Energy Recovery in Human Heart Failure
Anisha A. Gupte, Dale J. Hamilton, Andrea M. Cordero‐Reyes, Keith A. Youker, Zheng Yin, Jerry D. Estep, Robert David Stevens, Brett R. Wenner, Olga Ilkayeva, Matthias M. Loebe et al. · 2014 · Circulation Cardiovascular Genetics
Targeting the renin–angiotensin–aldosterone system in heart failure
Chim Choy Lang, Allan D. Struthers · 2013 · Nature Reviews Cardiology
Heart Failure in East Asia
Yutao Guo, Gregory Y.H. Lip, Amitava Banerjee · 2013 · Current Cardiology Reviews
Steroidal and Nonsteroidal Mineralocorticoid Receptor Antagonists Cause Differential Cardiac Gene Expression in Pressure Overload-induced Cardiac Hypertrophy
Jana Grune, Verena Benz, Sarah Brix, Janek Salatzki, Annelie Blumrich, Beata Hoeft, Robert Klopfleisch, Anna Foryst‐Ludwig, Peter Kolkhof, Ulrich Kintscher · 2016 · Journal of Cardiovascular Pharmacology
The Biology of Normal Zona Glomerulosa And Aldosterone-Producing Adenoma: Pathological Implications
Teresa Maria Seccia, Brasilina Caroccia, Elise P. Gómez-Sánchez, Celso E. Gómez-Sánchez, Gian Paolo Rossi · 2018 · Endocrine Reviews
Finerenone in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Rationale and Design of the FINEARTS-HF Trial
Muthiah Vaduganathan, Brian Lee Claggett, Carolyn S.P. Lam, Bertram Pitt, Michele Senni, Sanjiv Jayendra Shah, Adriaan A. Voors, Faiez M. Zannad, Akshay Suvas Desai, Pardeep S. Jhund et al. · 2024 · European Journal of Heart Failure
Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure
Lesley H. Curtis, Xiaojuan Mi, Laura Goettinger Qualls, Devon K. Check, Bradley G. Hammill, Stephen C. Hammill, Paul A. Heidenreich, Frederick A. Masoudi, Soko Setoguchi, Adrian F. Hernandez et al. · 2013 · American Heart Journal
Iron Deficiency in Community-Dwelling US Adults With Self-Reported Heart Failure in the National Health and Nutrition Examination Survey III
Ankit Parikh, Sundar Natarajan, Stuart R. Lipsitz, Stuart D. Katz · 2011 · Circulation Heart Failure
Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF
Docherty, Kieran F., Jhund, Pardeep S., Anand, Inder, Bengtsson, Olof, Böhm, Michael, de Boer, Rudolf A., DeMets, David L., Desai, Akshay S., Drozdz, Jaroslaw, Howlett, Jonathan et al. · 2020 · Circulation
Opposite Predictive Value of Pulse Pressure and Aortic Pulse Wave Velocity on Heart Failure With Reduced Left Ventricular Ejection Fraction
Véronique Regnault, Jérémy Lagrange, Anne Pizard, Michel E. Safar, Renaud Fay, Bertram Pitt, Pascal Challande, Patrick Rossignol, Faiez M. Zannad, Patrick J. Lacolley · 2013 · Hypertension
Heart Failure Around the World
Jasper Tromp, João Pedro Ferreira, Satit Janwanishstaporn, Monica Shah, Barry Greenberg, Faiez M. Zannad, Carolyn S.P. Lam · 2019 · European Journal of Heart Failure
Interactions Between Left Ventricular Ejection Fraction, Sex and Effect of Neurohumoral Modulators in Heart Failure
Pooja Dewan, Alice M. Jackson, Carolyn S.P. Lam, Marc Alan Pfeffer, Faiez M. Zannad, Bertram Pitt, Scott David Solomon, John J.V. McMurray · 2020 · European Journal of Heart Failure
Vascular Smooth Muscle Mineralocorticoid Receptor Contributes to Coronary and Left Ventricular Dysfunction After Myocardial Infarction
Alexandre Gueret, Najah Harouki, Julie Favre, Guillaume Galmiche, Lionel Nicol, Jean‐Paul Henry, Marie Besnier, Christian Thuillez, Vincent J. Richard, Peter Kolkhof et al. · 2016 · Hypertension
Rationale and Design of Mineralocorticoid Receptor Antagonist Tolerability Study-Heart Failure (ARTS-HF): A Randomized Study of Finerenone vs. Eplerenone in Patients who have Worsening Chronic Heart Failure with Diabetes and/or Chronic Kidney Disease
Bertram Pitt, Stefan D. Anker, Michael Böhm, Mihai Gheorghiade, Lars Køber, Henry Krum, Aldo Pietro Maggioni, Piotr P. Ponikowski, Adriaan A. Voors, Faiez M. Zannad et al. · 2015 · European Journal of Heart Failure
Fluid Management In Patients With Chronic Heart Failure
Pierpaolo Pellicori, Kuldeep Kaur, Andrew L. Clark · 2015 · Cardiac failure review
Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy
Christopher R. Heier, Qing Yu, Alyson A. Fiorillo, Christopher Tully, Asya Tucker, Davi A. G. Mázala, Kitipong Uaesoontrachoon, Sadish Srinivassane, Jesse M. Damsker, Eric P. Hoffman et al. · 2019 · Life Science Alliance
Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan
Naoki Kashihara, Shun Kohsaka, Eiichiro Kanda, Suguru Okami, Toshitaka Yajima · 2019 · Kidney International Reports
Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction
Matteo Serenelli, Alice M. Jackson, Pooja Dewan, Pardeep S. Jhund, Mark Colquhoun Petrie, Patrick Rossignol, Gianluca Calogero Campo, Bertram Pitt, Faiez M. Zannad, João Pedro Ferreira et al. · 2020 · JACC Heart Failure
Roles of Mineralocorticoid Receptors in Cardiovascular and Cardiorenal Diseases
Jonatan Barrera‐Chimal, Benjamin Bonnard, Frédéric Jaisser · 2022 · Annual Review of Physiology
Optimizing Foundational Therapies in Patients With HFrEF
Abhinav Sharma, Subodh Verma, Deepak L. Bhatt, Kim Alexander Connelly, Elizabeth Swiggum, Muthiah Vaduganathan, Shelley R. Zieroth, Javed Butler · 2022 · JACC Basic to Translational Science
Guidelines for Secondary Prevention of Myocardial Infarction (JCS 2011)
JCS Joint Working Group · 2012 · Circulation Journal
Rhythm Control in Heart Failure Patients With Atrial Fibrillation
Kevin M. Trulock, Sanjiv M. Narayan, Jonathan Paul Piccini · 2014 · Journal of the American College of Cardiology
Long-Term Effects of Spironolactone in Peritoneal Dialysis Patients
Yasuhiko Ito, Masashi Mizuno, Yasuhíro Suzuki, Hirofumi Tamai, Takeyuki Hiramatsu, Hiroshige Ohashi, Isao Ito, Hirotake Kasuga, Masanobu Horie, Shoichi Maruyama et al. · 2013 · Journal of the American Society of Nephrology
Neutrophil Gelatinase-Associated Lipocalin Is a Novel Mineralocorticoid Target in the Cardiovascular System
Céline Latouche, Soumaya El Moghrabi, Smail Messaoudi, Aurélie Nguyen Dinh Cat, Iván Hernández-Díaz, Diego Álvarez de la Rosa, Claudine Perret, Natalia López‐Andrés, Patrick Rossignol, Faiez M. Zannad et al. · 2012 · Hypertension
Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date
Lavanya Athithan, Gaurav Singh Gulsin, Gerry Patrick McCann, Eylem Levelt · 2019 · World Journal of Diabetes
Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care
Marco Trevisan, Edouard L. Fu, Yang Xu, Gianluigi Savarese, Friedo Wilhelm Dekker, Lars H. Lund, Catherine M. Clase, Arvid Sjölander, Juan Jesús Carrero · 2021 · European Journal of Heart Failure
Nonsteroidal mineralocorticoid receptor antagonism for cardiovascular and renal disorders − New perspectives for combination therapy
Peter Kolkhof, Amer Joseph, Ulrich Kintscher · 2021 · Pharmacological Research
Rationale and Design of ARTS: A Randomized, Double-Blind Study of BAY 94-8862 in Patients with Chronic Heart Failure and Mild or Moderate Chronic Kidney Disease
Bertram Pitt, Gerasimos S Filippatos, Mihai Gheorghiade, Lars Køber, Henry Krum, Piotr P. Ponikowski, Christina Nowack, Peter Kolkhof, So‐Young Kim, Faiez M. Zannad · 2012 · European Journal of Heart Failure
Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure
João Pedro Ferreira, Mário Santos, Sofia Almeida, Irene Marques, Paulo Bettencourt, Henrique Cyrne Carvalho · 2013 · European Journal of Internal Medicine
Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fraction
Frank Edelmann, Andreas Tomaschitz, Rolf Wachter, Götz Gelbrich, M. Knoke, Hans‐Dirk Düngen, Stefan Pilz, Lutz Binder, Raoul Stahrenberg, Albrecht G. Schmidt et al. · 2011 · European Heart Journal
Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectives
Bertram Pitt, João Pedro Ferreira, Faiez M. Zannad · 2016 · European Heart Journal - Cardiovascular Pharmacotherapy
Biomarkers to Guide Medical Therapy in Primary Aldosteronism
Gregory L. Hundemer, Alexander A. C. Leung, Gregory A. Kline, Jenifer Michelle Brown, Adina F. Turcu, Anand Vaidya · 2023 · Endocrine Reviews
International Geographic Variation in Event Rates in Trials of Heart Failure With Preserved and Reduced Ejection Fraction
Søren Lund Kristensen, Lars Køber, Pardeep S. Jhund, Scott David Solomon, JOHN K. KJEKSHUS, Robert Samuel McKelvie, Michael R. Zile, Christopher Bull Granger, John Wikstrand, Michel Komajda N et al. · 2014 · Circulation
Rationale and Design of the DIGIT-HF Trial (DIGitoxin to Improve Outcomes in Patients with Advanced Chronic Heart Failure): A Randomized, Double-Blind, Placebo-Controlled Study
Udo Bavendiek, Dominik Berliner, Lukas Aguirre Dávila, Johannes Schwab, Lars Siegfried Maier, Sebastian Philipp, Andreas J. Rieth, Ralf Westenfeld, Christopher Piorkowski, Kristina Weber et al. · 2019 · European Journal of Heart Failure
Medical Therapies for Heart Failure With Preserved Ejection Fraction
Sverre Erik Kjeldsen, Thomas G. von Lueder, Otto Armin Smiseth, Kristian Wachtell, Nisha Mistry, Arne S. Westheim, Ingrid Hopper, Stevo Julius, Bertram Pitt, Christopher Michael Reid et al. · 2019 · Hypertension
2020 Clinical practice guidelines for Chronic heart failure
Russian Society of Cardiology · 2020 · Russian Journal of Cardiology
Cystatin C Identifies Patients With Stable Chronic Heart Failure at Increased Risk for Adverse Cardiovascular Events
Matthias Dupont, Yuping Wu, Stanley L. Hazen, W.H. Wilson Tang · 2012 · Circulation Heart Failure
Chagas Cardiomyopathy
Catherine Pastorius Benziger, Gabriel Assis Lopes do Carmo, Antônio Luiz Pinho Ribeiro · 2016 · Cardiology Clinics
Thrombo-Embolism and Antithrombotic Therapy for Heart Failure in Sinus Rhythm. A Joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis
Gregory Y.H. Lip, Piotr Ponikowski, Felicita Andreotti, Stefan D. Anker, Gerasimos Filippatos, Shunichi Homma, João Morais, Patrick M. Pullicino, Lars Hvilsted Rasmussen, Francisco R. Marín et al. · 2012 · European Journal of Heart Failure
Cost-effectiveness of heart failure therapies
Luís Eduardo Paim Rohde, Eduardo Gehling Bertoldi, Lívia Adams Goldraich, Carísi Anne Polanczyk · 2013 · Nature Reviews Cardiology
Effect of Spironolactone on 30-Day Death and Heart Failure Rehospitalization (from the COACH Study)
Alan S. Maisel, Yang Xue, Dirk Jan van Veldhuisen, Adriaan A. Voors, Tiny Jaarsma, Peter S. Pang, Javed Butler, Bertram Pitt, Paul Clopton, Rudolf A. de Boer · 2014 · The American Journal of Cardiology
CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats
Kiyoshi Arai, Hiroyuki Tsuruoka, Tsuyoshi Homma · 2015 · European Journal of Pharmacology
The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial
Timothy John Collier, Stuart Pocock, John J.V. McMurray, Faiez M. Zannad, Henry Krum, Dirk Jan van Veldhuisen, Karl B Swedberg, Harry H. Shi, John Vincent, Bertram Pitt · 2013 · European Heart Journal
True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: A meta-analysis
Davor Vukadinović, Daniel Lavall, Aleksandra Nikolovska Vukadinović, Bertram Pitt, Stefan Wagenpfeil, Michael Böhm · 2017 · American Heart Journal
Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and Improves Cardiac Function in Heart Failure
Kevin Morine, Xiaoying Qiao, Sam York, PETER S. NATOV, Vikram Paruchuri, Yali Zhang, Mark J. Aronovitz, Richard H. Karas, Navin Kumar Kapur · 2018 · Circulation
RAAS Inhibitors and Cardiovascular Protection in Large Scale Trials
Thomas G. von Lueder, Henry Krum · 2012 · Cardiovascular Drugs and Therapy
Diabetic cardiomyopathy: from pathophysiology to treatment.
Konstantinos Trachanas, Skevos K. Sideris, Constantina Aggeli, Emmanouil Poulidakis, Konstantinos A. Gatzoulis, Dimitrios M. Tousoulis, Ioannis E. Kallikazaros · 2014 · PubMed
Diuretic Therapy in Heart Failure – Current Approaches
Gavino Casu, Pierluigi Merella · 2015 · European Cardiology Review
Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials
Xavier Rosselló, Cono A. Ariti, Stuart Pocock, João Pedro Ferreira, Nicolas Girerd, John J.V. McMurray, Dirk Jan van Veldhuisen, Bertram Pitt, Faiez M. Zannad · 2018 · Clinical Research in Cardiology
Aldosterone-Specific Activation of Cardiomyocyte Mineralocorticoid Receptor In Vivo
Smail Messaoudi, Basile Gravez, Antoine Tarjus, Véronique Pelloux, Antoine Ouvrard‐Pascaud, Claude Delcayre, Jane‐Lise Samuel, Jean‐Marie Launay, Catalina Sierra‐Ramos, Diego Álvarez de la Rosa et al. · 2013 · Hypertension
Non-Steroidal Mineralocorticoid Receptor Antagonism for the Treatment of Cardiovascular and Renal Disease
Peter Bramlage, Stephanie Louise Swift, Martin Thoenes, Joan Minguet, Carmen Ferrero, Roland Erich Schmieder · 2015 · European Journal of Heart Failure
Medication Dosing for Heart Failure with Reduced Ejection Fraction — Opportunities and Challenges
Catherine Norton Marti, Gregg C. Fonarow, Stefan D. Anker, Clyde W. Yancy, Muthiah Vaduganathan, Stephen John Greene, Ali Ahmed, James L. Januzzi, Mihai Gheorghiade, Gerasimos S Filippatos et al. · 2018 · European Journal of Heart Failure
Finerenone: third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease
Licette C.Y. Liu, Elise Schutte, Ron T. Gansevoort, Peter van der Meer, Adriaan A. Voors · 2015 · Expert Opinion on Investigational Drugs
Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection
Fernando L. Martín, Paul M. McKie, Alessandro Cataliotti, S. Jeson Sangaralingham, Josef K. Korinek, Brenda K. Huntley, Elise A. Oehler, Gerald E. Harders, Tomoko Ichiki, Sarah Mangiafico et al. · 2011 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure
Davide Castagno, Mark Colquhoun Petrie, Brian Lee Claggett, John J.V. McMurray · 2012 · European Heart Journal
Mineralocorticoid Receptor Antagonists: a Comprehensive Review of Finerenone
Juan Simón Rico-Mesa, Averi White, Ashkan Ahmadian-Tehrani, Allen S. Anderson · 2020 · Current Cardiology Reports
CONSENSUS to EMPHASIS: The Overwhelming Evidence which Makes Blockade of the Renin–Angiotensin–Aldosterone System the Cornerstone of Therapy for Systolic Heart Failure
John J.V. McMurray · 2011 · European Journal of Heart Failure
Preclinical pharmacology of AZD9977: A novel mineralocorticoid receptor modulator separating organ protection from effects on electrolyte excretion
Krister Bamberg, Ulrika Johansson, Karl Edman, Lena William‐Olsson, Susanna Myhre, Anders Gunnarsson, Stefan Geschwindner, Anna Aagaard, Anna Granqvist, Frédéric Jaisser et al. · 2018 · PLoS ONE
ACE inhibitors and ARBs: Managing potassium and renal function
Tasnim Momoniat, Duha Ilyas, Sunil Bhandari · 2019 · Cleveland Clinic Journal of Medicine
Nocturnal Hypertension and Heart Failure: Mechanisms, Evidence, and New Treatments
Kazuomi Kario, Bryan Williams · 2021 · Hypertension
Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease
Arjun K. Pandey, Deepak L. Bhatt, Francesco Cosentino, Nikolaus Marx, Ori David Rotstein, Bertram Pitt, Ambarish Pandey, Javed Butler, Subodh Verma · 2022 · European Heart Journal
The Cardio-Kidney Patient: Epidemiology, Clinical Characteristics and Therapy
Katharina Andrea Schuett, Nikolaus Marx, Michael Lehrke · 2023 · Circulation Research
Pathophysiology and Therapy of Cardiac Dysfunction in Duchenne Muscular Dystrophy
Daniel Philip Judge, David A. Kass, William Reid Thompson, Kathryn R. Wagner · 2011 · American Journal of Cardiovascular Drugs
Clinical Pharmacokinetics of Drugs in Patients with Heart Failure: An Update (Part 2, Drugs Administered Orally)
Ryuichi Ogawa, Joan M Stachnik, Hirotoshi Echizen · 2014 · Clinical Pharmacokinetics
EMPA-REG – the “diuretic hypothesis”
John J.V. McMurray · 2015 · Journal of Diabetes and its Complications
Mineralocorticoid Receptor Blocker Eplerenone Improves Endothelial Function and Inhibits Rho-Associated Kinase Activity in Patients With Hypertension
N Fujimura, Kensuke Noma, T Hata, Junko Soga, Takayuki Hidaka, Naomi Idei, Yuichi Fujii, S Mikami, Tatsuya Maruhashi, Y Iwamoto et al. · 2011 · Clinical Pharmacology & Therapeutics
Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What's Old Is New Again
Kurt W. Prins, Thenappan Thenappan, Ε. Kenneth Weir, Rajat Kalra, MARC R. PRITZKER, Stephen L. Archer · 2018 · Journal of the American Heart Association
Making Sense of Statistics in Clinical Trial Reports
Stuart Pocock, John J.V. McMurray, Timothy John Collier · 2015 · Journal of the American College of Cardiology
Cardiorenal Syndrome in Critical Care: The Acute Cardiorenal and Renocardiac Syndromes
Dinna N. Cruz · 2012 · Advances in Chronic Kidney Disease
Approach and Management of Hypertension After Kidney Transplantation
Ekamol Tantisattamo, Miklos Zsolt Molnar, Bing Ho, Uttam G. Reddy, Donald C. Dafoe, Hirohito Ichii, Antoney Ferrey, Ramy Magdy Hanna, Kamyar Kalantar‐Zadeh, Alpesh Amin · 2020 · Frontiers in Medicine
Cardiovascular Outcomes in Patients With Diabetes and Kidney Disease
Javier Morales, Yehuda Handelsman · 2023 · Journal of the American College of Cardiology
Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure
Joshua D. Newman, Eileen O’Meara, Michael Böhm, Gianluigi Savarese, Patricia R. Kelly, Orly Vardeny, Larry A. Allen, Patrizio Lancellotti, Stephen S. Gottlieb, Zainab Z. Samad et al. · 2024 · Journal of the American College of Cardiology
Medical therapy for chronic heart failure
Henry Krum, John R. Teerlink · 2011 · The Lancet
Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)
Preiss, David, van Veldhuisen, Dirk J., Sattar, Naveed, Krum, Henry, Swedberg, Karl, Shi, Harry, Vincent, John, Pocock, Stuart J., Pitt, Bertram, Zannad, Faiez et al. · 2012 · European Journal of Heart Failure
Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica
Frank L.J. Visseren, François Mach, Yvo Michiel Smulders, David Carballo, Konstantinos C. Koskinas, Maria Bäck, Athanase Bénétos, Alessandro Biffi, José Manuel Boavida, Davide Capodanno et al. · 2022 · Revista Española de Cardiología
Brain mineralocorticoid receptors in cognition and cardiovascular homeostasis
Elise P. Gómez-Sánchez · 2014 · Steroids
Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges
Faiez M. Zannad, Wendy Gattis Stough, Véronique Regnault, Mihai Gheorghiade, Efthymios Deliargyris, Charles Michael Gibson, Stefan Agewall, Scott D. Berkowitz, Paul B.J. Burton, Gonzalo Calvo et al. · 2013 · International Journal of Cardiology
A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone
Natalia López‐Andrés, Beatriz Martín‐Fernández, Patrick Rossignol, Faiez M. Zannad, Vicente Lahera, María Antonia Fortuño, Victoria Cachofeiro, Javier Dı́ez · 2011 · American Journal of Physiology-Heart and Circulatory Physiology
Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives
Marco Merlo, Thomas Caiffa, Marco Gobbo, Luigi Adamo, Gianfranco Sinagra · 2018 · IJC Heart & Vasculature
Understanding Heart Failure
Jeremy Aryeh Mazurek, Mariell L Jessup · 2015 · Cardiac Electrophysiology Clinics
Aldosterone, oxidative stress, and NF-κB activation in hypertension-related cardiovascular and renal diseases
Nina Queisser, Nicole Schupp · 2012 · Free Radical Biology and Medicine
Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy
Micha Tobias Maeder, Hans Rickli, Matthias Emil Pfisterer, Stefano Muzzarelli, Peter Ammann, Thomas Hans Fehr, Dietrich Hack, Daniel Weilenmann, Thomas Dieterle, Stephanie Kiencke et al. · 2012 · American Heart Journal